Sempra (SRE)

NYSE: SRE · USD

$84.6

-0.37 (-0.4%)· Recorded snapshot

Dự phòng tiếng AnhVI

Hiển thị bản gốc tiếng Anh trong khi đang dịch

Báo cáo này chưa được dịch. Hãy làm mới sau vài phút khi hàng đợi dịch xử lý xong.

StockMarketAgent Research · Analyzed 2026-10-03

Our latest published analysis: SRE rated Buy

Sempra's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$91.1 / share

Potential value

$124 / share

Upside to FV

+16.3%

from $84.6

Moat

6.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$51.3B
Revenue (ttm)	13.6B
Net income (ttm)	2.3B
EPS (ttm)	$3.46
Shares out	653.9M
P/E (trailing)	24.4x
P/E (forward)	14.5x
Dividend	$2.63 (3.10%)
Volume	1,599,902
Beta	0.56

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.6B
Net income (ttm): 2.3B
EPS (ttm): $3.46
P/E (trailing): 24.4x
P/E (forward): 14.5x
Market cap: $51.3B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$11.68B	$13.72B	$14.85B	$11.82B	$12.42B	+1.6%
Gross profit	$3.64B	$4.16B	$3.75B	$3.52B	$4.00B	+2.3%
Operating income	$1.41B	$2.40B	$3.89B	$3.41B	$4.31B	+32.3%
Net income	$1.32B	$2.14B	$3.08B	$2.86B	$1.84B	+8.7%
EPS (diluted)	$2.01	$3.31	$4.79	$4.42	$2.75	+8.2%
EBITDA	$3.26B	$4.42B	$6.12B	$5.85B	$6.87B	+20.5%
R&D	—	—	—	—	—	—
SG&A	$4.93B	—	—	—	—	—

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Bán
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Giảm
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	Giữ
AEE	Ameren Corporation	29.9B	19.1x	3.6x	4.4%	+8.0%	+6.0%	Giữ
AEP	American Electric Power Company Inc.	69.8B	20.9x	3.0x	4.3%	+7.6%	+13.5%	Giữ
CEG	Constellation Energy Corporation	91.4B	25.0x	2.9x	7.4%	+10.8%	-33.6%	Bán

Base and Bull scenarios

Base60%

Price target

$91.14

+16.3% from spot

In the base case, Sempra executes on its core regulated utility mandate, with Sempra California delivering predictable rate-base compounding under CPUC revenue decoupling mechanisms. Operating margins stabilize near historical utility levels, while consolidated revenue grows at a measured pace. Transformation capex moderates in an orderly fashion from peak levels across the forecast period, narrowing the free cash flow deficit as the initial ECA LNG export phase enters service. Consensus forward EPS growth supports sustainable dividend compounding.

CPUC authorized ROE remains stable with standard annual rate base additions supporting Sempra California revenue of $11,454M
Consolidated operating margin holds stable near historical levels supporting operating income of $3,253M
Reinvestment rate steps down across the forecast period as transformation capex ($10,612M in FY2025) moderates
Consensus diluted EPS reaches $5.11 in FY2026 and $5.54 in FY2027
Cost of equity is 7.1336% with perpetual terminal growth rate reflecting steady-state economic growth

Bull20%

Price target

$124.47

+58.8% from spot

In the upside scenario, CPUC rate case determinations award robust rate base expansion allowances and favorable ROE authorisations without cost disallowance. Sempra California compounds earnings above historical rates, while Sempra Infrastructure commissions the initial phase of ECA LNG ahead of schedule, expanding high-margin take-or-pay revenues from Mexico. Capex normalizes rapidly from peak capital expenditure levels toward maintenance, inflecting free cash flow into substantial positive generation and supporting multiple expansion toward peer utility medians.

CPUC authorized ROE maintained with full rate-base recognition of grid safety investments supporting Sempra California revenue of $11,454M
Sempra Infrastructure successfully commissions ECA LNG initial phase on schedule, expanding Mexico revenue beyond historical levels
Capex normalizes toward recurring maintenance levels, inflecting free cash flow from FY2025 levels of -$6,047M to positive cash generation
Forward valuation multiple re-rates toward peer utility medians

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($91.14). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.3%	2.5%	2.8%	3.0%
6.1%	$100	$104	$108	$113	$118
6.6%	$92.7	$95.4	$98.6	$102	$106
7.1%	$86.5	$88.7	$91.1	$93.9	$96.9
7.6%	$81.3	$83.1	$85.1	$87.3	$89.7
8.1%	$76.9	$78.4	$80.0	$81.8	$83.7

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E14.5

P25 n/aP50 n/aP75 n/a

Trailing P/E22.6

P25 n/aP50 n/aP75 n/a

ROE6.7

P25 n/aP50 n/aP75 n/a

ROIC2.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SRE indicators

Market & fundamental data

Available fields

267

Groups with data

Currency

USD

Showing 267 of 267 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001032208
Company name	Sempra
Country	United States
Country code	US
CUSIP number	816851109
Earnings date	2026-11-05
Earnings time	bmo
Employees	28,451
Employees change	-1,930
Employees growth	-6.35%
Enterprise value	$92B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
In index	SP500
Industry	Utilities - Diversified
Is primary listing	Yes
Is SPAC	No
ISIN number	US8168511090
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2023-08-22
Last stock split type	Forward
Market cap	$55.3B
Market cap category	Large-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$84.64
Price currency	USD
Sector	Utilities
SIC code	4932
Stock price date	2026-10-28
Symbol	SRE
U.S. state	California
Website	https://www.sempra.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	16.73x
Average P/E ratio (10Y)	28.49x
Average P/E ratio (3Y)	21.29x
Average P/E ratio (5Y)	25.22x
Earnings yield	4.09%
EV/Earnings	40.81x
EV/EBIT	27.39x
EV/EBITDA	15.72x
EV/Sales	6.81x
FCF / EV yield	-5.68%
FCF yield	-9.41%
Forward EV/Sales	6.47x
Forward P/E	16.02x
Forward P/S	3.9x
Graham number	62.40247
Graham upside	-26.74%
Industry forward P/E	14.51x
Industry P/E	18.91x
Lynch fair value	$17.31
Lynch upside	-79.68%
P/(OCF - SBC) ratio	10.47x
P/B ratio	1.7x
P/E ratio	24.45x
P/OCF ratio	10.28x
P/S ratio	4.11x
PEG ratio	1.91x
Price / tangible book value	1.7x
Price/EBITDA ratio	9.48x
Sector forward P/E	17.04x
Sector P/E	19.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.87%
EBITDA margin	43.34%
Effective tax rate	19.24%
Gross margin	43.99%
Operating margin	24.87%
Pretax margin	24.9%
Profit margin	16.82%
Profit per employee	$79,505
Profitable quarters	19
Profitable years	30
Revenue per employee	$476,328
ROA	1.96%
ROA (5Y)	2.21%
ROCE	3.62%
ROE	6.68%
ROE (5Y)	8.03%
ROIC	2.68%
SBC / revenue	0.72%
Tax / revenue	4.79%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-16.22%
EPS growth (Q)	71.31%
EPS growth (QoQ)	-23.42%
EPS growth 10Y	5.83%
EPS growth 3Y	-4.3%
EPS growth 5Y	0.42%
EPS growth quarters	2
EPS growth years	0
Net income growth	-15.99%
Net income growth (Q)	68.64%
Net income growth (QoQ)	-23.24%
Net income growth 3Y	-3.22%
Net income growth 5Y	1.86%
Net income growth quarters	2
Net income growth years	0
OCF growth	16.4%
OCF growth (Q)	66.84%
OCF growth (QoQ)	-27.69%
OCF growth 10Y	7.61%
OCF growth 3Y	29.14%
OCF growth 5Y	7.24%
Revenue growth	1.62%
Revenue growth (Q)	-0.1%
Revenue growth (QoQ)	-18%
Revenue growth 10Y	3.13%
Revenue growth 3Y	-7.22%
Revenue growth 5Y	2.78%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-10.7B
Depreciation and amortization	$2.5B
EBIT	$3.4B
EBITDA	$5.9B
EPS	$3.46
FCF per share	$-8.02
Financing cash flow	$10.2B
Free cash flow	$-5.2B
Free cash flow minus SBC	$-5.3B
Gross profit	$6B
Income taxes	$649M
Investing cash flow	$-13.1B
Net borrowing	$7.7B
Net cash flow	$2.5B
Net income	$2.3B
Operating cash flow minus SBC	$5.3B
Operating income	$3.4B
Revenue	$13.6B
Stock-based compensation	$97M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$50.00
Debt / EBITDA	5.79
Debt / equity	0.85
Interest coverage	2.17
Long-term assets	$79B
Long-term liabilities	$49.9B
Net cash (debt)	$-36.6B
Net cash / market cap	-65.74%
Net debt / EBITDA	6.23
Net debt / equity	0.85
Piotroski F-Score	5
Property, plant and equipment	$51B
Shareholders' equity	$43.3B
Tangible book value	$32.7B
Tangible book value per share	$50.00
Total assets	$115.3B
Total cash	$48M
Total debt	$36.7B
Total liabilities	$72B
WACC	5.78%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.13
Current assets	$36.3B
Current liabilities	$22.1B
Current ratio	1.64
Inventory turnover	13.54
Net working capital	$19.8B
Quick ratio	0.09
Working capital	$14.2B
Working capital turnover	2.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.32%
Dividend growth	2.45%
Dividend growth (10Y)	5.85%
Dividend growth (3Y)	3.55%
Dividend growth (5Y)	3.8%
Dividend growth years	15
Dividend payment date	2026-10-15
Dividend payment years	29
Dividend payout frequency	Quarterly
Dividend per share	$2.63
Dividend yield	3.1%
Ex-dividend date	2026-09-24
Last dividend	$0.66
Payout ratio	75.97%
Shareholder yield	1.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	61.75%
10Y return CAGR	8.29%
10Y total return	121.7%
150-day SMA	$88.83
15Y price change	209.38%
15Y return CAGR	11.23%
15Y total return	393.31%
1D price change	-0.44%
1M price change	8.52%
1M total return	8.52%
1W price change	2.13%
1W total return	2.13%
1Y price change	-9.23%
1Y return CAGR	-6.5%
1Y total return	-6.5%
20-day SMA	$81.90
200-day SMA	$89.52
20Y price change	218.53%
20Y return CAGR	9.25%
20Y total return	486.75%
3M price change	-7.32%
3M total return	-6.54%
3Y price change	21.3%
3Y return CAGR	10.04%
3Y total return	33.26%
50-day SMA	$82.24
50-day SMA vs 200-day SMA	50under200
52-week high	$101.04
52-week high date	2026-04-09
52-week low	$76.21
52-week low date	2026-09-29
5Y price change	30.24%
5Y return CAGR	8.78%
5Y total return	52.32%
6M price change	-8.53%
6M total return	-7.11%
All-time high	$101.04
All-time high date	2026-04-09
All-time low	$7.75
All-time low date	2002-07-24
Average true range (ATR)	$1.35
Average volume	2.9M
Beta (1Y)	-0.46
Beta (2Y)	0.43
Beta (5Y)	0.56
Change from 52-week high	-16.24%
Change from 52-week low	11.06%
Change from all-time high	-16.3%
Change from all-time low	991.23%
Change from open	-0.44%
Day's gap	0%
Dollar volume	$135.4M
High price	$85.31
Low price	$84.44
Monthly RSI	49.83
Open price	$85.01
Position in 52-week range	22.41%
Premarket change	0.11%
Premarket close	$85.01
Premarket price	$85.10
Previous close	$85.01
Price vs 150-day SMA	-4.79%
Price vs 20-day SMA	3.26%
Price vs 200-day SMA	-5.53%
Price vs 50-day SMA	2.83%
Relative volume	0.55
RSI	60.33
Sharpe ratio	-0.43
Sharpe ratio (3Y)	0.39
Sharpe ratio (5Y)	0.3
Sortino ratio	-0.3
Sortino ratio (3Y)	0.73
Sortino ratio (5Y)	0.63
Volume	1.6M
Weekly RSI	47.05
YTD price change	-4.21%
YTD total return	-2.04%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	652.5M
Float percentage	99.79%
Shares change (QoQ)	0.07%
Shares change (YoY)	1.32%
Shares held by insiders	0.05%
Shares held by institutions	93.54%
Shares outstanding	653.9M
Short % of float	2.04%
Short % of shares	2.04%
Short ratio	3.3 days

Deeper analysis on SRE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this SRE report

What is the latest published SRE stock rating?

Sempra is shown with Buy in the latest published report, analyzed 2026-10-03. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SRE analysis?

The full latest published report, analyzed 2026-10-03, lives at /stocks/SRE/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for SRE?

The latest published report analyzed 2026-10-03 gives SRE a fair value of USD 91 and a potential value of USD 124. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the SRE page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-03). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

BuySRE · Fair value $91.1+16.3%

Read full analysis →

Category	Score	Reading
Valuation	7.5
Management	7.5
Balance Sheet	6.0
Profitability	5.5
Revenue Growth	2.5
Risk Assessment	7.5
Competitive Moat	6.5
Earnings Quality	9.0
Capital Efficiency	2.5

Sempra (SRE)

Our latest published analysis: SRE rated Buy

Price

Financial snapshot

Fair-value bridge

Latest news · SRE

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All SRE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SRE

Frequently asked questions

Lịch sử xếp hạng